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Aetiology of neurodegenerative mechanisms underlying Alzheimer’s disease (AD) are
still under elucidation. The contribution of cerebrovascular deficiencies (such as cerebral
ischemia/stroke) has been strongly endorsed in recent years. Reduction of blood
supply leading to hypoxic condition is known to activate cellular responses mainly
controlled by hypoxia-inducible transcription factor-1 (HIF-1). Thus alterations of oxygen
responsive HIF-1α subunit in the central nervous system may contribute to the cognitive
decline, especially influencing mechanisms associated to amyloid precursor protein (APP)
amyloidogenic metabolism. Although HIF-1α protein level is known to be regulated by von
Hippel-Lindau (VHL) ubiquitin-proteasome system, it has been recently suggested that
glycogen synthase kinase-3β (Gsk-3β) promotes a VHL-independent HIF-1α degradation.
Here we provide evidences that in rat primary hippocampal cell cultures, HIF-1α
degradation might be mediated by a synergic action of Gsk-3β and peptidyl-prolyl cis/trans
isomerase (Pin1). In post-ischemic conditions, such as those mimicked with oxygen
glucose deprivation (OGD), HIF-1α protein level increases remaining unexpectedly high
for long time after normal condition restoration jointly with the increase of lactate
dehydrogenase (LDH) and β-secretase 1 (BACE1) protein expression (70 and 140%
respectively). Interestingly the Pin1 activity decreases about 40–60% and Pin1S16
inhibitory phosphorylation significantly increases, indicating that Pin1 binding to its
substrate and enzymatic activity are reduced by treatment. Co-immunoprecipitation
experiments demonstrate that HIF-1α/Pin1 in normoxia are associated, and that in
presence of specific Pin1 and Gsk-3β inhibitors their interaction is reduced in parallel to an
increase of HIF-1α protein level. Thus we suggest that in post-OGD neurons the high level
of HIF-1α might be due to Pin1 binding ability and activity reduction which affects HIF-1α
degradation: an event that may highlight the relevance of ischemia/HIF-1α as a risk factor
in AD pathogenesis.
Keywords: Alzheimer’s disease, cerebrovascular deficiencies, hippocampal neurons, Pin1, HIF-1α, GSK-3β, oxygen
glucose deprivation
INTRODUCTION
Alzheimer’s disease (AD) is a multifactor neurodegenerative
pathology affecting the elderly population. The pathogenesis of
sporadic late-onset AD has not been identified, but further studies
support that cerebral ischemia/stroke significantly increases AD
Abbreviations: PAGE, polyacrylamide gel electrophoresis; SDS, sodium
dodecyl sulphate; SEM, standard error media; TBST, Tris-buffered saline-
Tween; OGD, oxygen glucose deprivation; Ara-C, 1-β-D arabinofura-
nosylcytosine; BSS, balanced salt solution; LDS, lauryl-dodecyl sulphate;
ECL, enhanced chemiluminescence; DMSO, dimethyl sulfoxide; pNA,
p-nitroanilide; juglone, 5-Hydroxy-1,4-naphtoquinone; APP, amyloid
precursor protein; PI3K, phosphatidylinositol-3 kinase; Pin1, peptidyl-prolyl
cis/trans isomerase (PPIase); HIF-1α, hypoxia-inducible transcription factor
subunit-α; Gsk-3β, glycogen synthase kinase-3β; BACE1, β-secretase 1; LDH,
lactate dehydrogenase; VHL, von Hippel-Lindau protein.
risk (Kalaria, 2000; Zhang et al., 2007). Indeed, it has been sug-
gested that cerebral hypoperfusion causing neuronal damage in
vulnerable brain areas (Koistinaho and Koistinaho, 2005; Zhang
et al., 2007) may serve as a basis for some cases of dementia after
stroke (Ogunshola and Antoniou, 2009).
At the molecular level, a large percentage of hypoxic responses
are controlled by hypoxia-inducible transcription factor-1
(HIF-1; Webb et al., 2009) whose involvement in neurodegenera-
tive disorders is becoming widely accepted, although its role may
greatly depend on whether it is the cause or the consequence in
disease progression (Ogunshola and Antoniou, 2009; Bulbarelli
et al., 2012).
HIF-1 is a heterodimeric protein composed of a constitu-
tively expressed HIF-1β subunit and oxygen-regulated HIF-1α
subunit (Wang et al., 2006). Under hypoxic conditions HIF-1α
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is stabilized, and in complex to the constitutive HIF-1β sub-
unit induces the transcription of a plethora of genes (Semenza,
2003), whereas in normoxic conditions it is rapidly sub-
jected to proteasomal degradation (Webb et al., 2009). HIF-
1α degradation system displays enormous plasticity since it
can be induced by hydroxylation and phosphorylation events
either alone or in combination (Flügel et al., 2007). Indeed,
although HIF-1α degradation mainly depends on two prolyl
hydroxylation allowing the binding with tumor suppressor von
Hippel-Lindau protein (VHL; Salceda and Caro, 1997; Sonenberg
and Gingras, 1998; Semenza, 2010), evidences show that glyco-
gen synthase kinase-3β (Gsk-3β), by phosphorylation of Ser551,
Thr555, and Ser589 residues in HIF-1α oxygen degradation
domain (ODD), can promote its ubiquitination and proteaso-
mal degradation in a VHL-independent manner (Flügel et al.,
2007).
In addition, during a brief hypoxic event, the HIF-1α protein
stabilization needs the Akt-induced inhibitory phosphorylation
of Gsk-3β on Ser9 residue (Mottet et al., 2003). A growing number
of reports showed that both hypoxic and non hypoxic stimuli
appear to promote HIF-1α stabilization by means of PI3K/Akt
pathway (Zhong et al., 2000; Zundel et al., 2000; Hirota and
Semenza, 2001; Li et al., 2008) in a cell and tissue specific way
(such as in cortical neurons; Zhang et al., 2009).
The Gsk-3β-mediated degradation of HIF-1α implies a sce-
nario similar to that of c-myc and cyclin E (Yeh et al., 2004,
2006) which upon phosphorylation by the kinase and isomerase-
mediated conformational change, are ubiquitinated and degraded
in the proteasome. Gsk-3β can indeed cooperate synergistically
with the peptidyl-prolyl cis/trans isomerase (Pin1) in ubiquiti-
nation of a wide range of proteins (Liou et al., 2011). Gsk-
3β as a proline-directed kinase can selectively phosphorylate
Ser/Thr-Pro residues allowing the Pin1 substrate recognition and
their cis to trans isomerization. The cis or trans conformation
of phospho-Ser/Thr-Pro motif, as recently suggested, could be a
crucial determinant in regulating protein degradation (Liou et al.,
2011) in view of the fact that the ubiquitin E3 ligase complex
might have a structural preference for phosphorylated substrates
via a trans conformation. Pin1-mediated conformational change
in phospho-Ser/Thr-Pro motifs, hence, represents a novel molec-
ular switch in a large number of biological processes. Therefore,
Pin1 is tightly regulated by multiple levels (Lu et al., 2002), and
alterations in its functionality often lead to several pathologies,
included cancer and neurodegeneration (such as AD; Lu et al.,
2007). In pathological conditions, the Pin1 ability to interact with
downstream substrates is inhibited by phosphorylation of Ser16
residue in its binding domain (Eckerdt et al., 2005; Lonati et al.,
2011) while oxidative modification in the catalytic domain can
abolish the enzymatic activity of isomerase (Butterfield et al.,
2006a,b).
Although recent studies highlight indirect link between HIF-
1α regulation/activity and Pin1 overexpression in breast cancer
(Kim et al., 2008) and in prostate cancer (Yuan et al., 2011), little
is known about the relationship of this two proteins in neuronal
tissues, under physiological or pathological conditions. Consis-
tent with that we asked whether Pin1 might participate in HIF-
1α modulation under normoxic and post-ischemic conditions,
such as those mimicked after oxygen glucose deprivation (OGD)
treatment, where HIF-1α protein levels are carefully regulated and
Pin1 activity might be altered.
Here we show that, in rat primary hippocampal cultures, Pin1
interacts with HIF-1α, and catalyzing its isomerization plays a
central role in Gsk-3β-mediated proteasomal degradation of the
transcription factor. Moreover in neurons subjected to OGD, Pin1
binding and activity interestingly are partially inhibited affecting
HIF-1α ubiquitination and protein level.
Considering that recent studies performed in the central
nervous system highlight the pathophysiological relevance of
hypoxia/HIF-1 pathways regulation of β-secretase 1 (BACE1)
expression and amyloid precursor protein (APP) amyloidogenic
metabolism (Zhang et al., 2007; Bulbarelli et al., 2012), alterations
in HIF-1α protein levels/degradation pathway may contribute to
the cognitive decline and dementia in AD patients influencing the
disease course.
MATERIALS AND METHODS
MATERIALS
All commercial chemicals were of the highest available grade:
Sprague-Dawley rats were from Charles-River Laboratories
(Lecco, Italy). The 5% CO2: 95% N2 gas cylinder was from
Sapio, Monza, Italy. Complete protease inhibitor cocktail was
from Roche Diagnostics S.p.A (Milano, Italy). Hydroxy-1,4-
naphtoquinone (juglone), Lactacystin, 1-β-D arabinofuranosyl-
cytosine (Ara-C), lithium chloride solution, SB-216763 Gsk-3
inhibitor, solutions for electrophoresis were from Sigma Chem-
ical Co. (Milano, Italy). All the stock solutions for cell culture
were from Euroclone (Celbio Milano, Italy). Gibco Neurobasal
medium (NBM) and B27 supplement, Dynabeads® protein G,
sodium dodecyl sulphate (SDS) NuPAGE reagents (4–12% Bis-
Tris gel; sample buffer; running buffer), Novex Sharp Protein
Standard, anti-Tau was from Life Technologies (Milano, Italy).
Anti-Pin1, anti P-Pin1S16 and anti-Ubiquitin (PD41) were
from Cell Signaling (Beverly, USA). Anti-HIF-1α and anti-lactate
dehydrogenase (LDH) antibodies were from Abcam (Cambridge
Science Park, UK). Anti P-Ser/Thr-Pro (MPM2) and Anti-Pin1
for immunoprecipitation antibodies were from Millipore S.p.A
(Milano, Italy). Anti-BACE1 antibody was from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA, USA). Secondary HRP-
conjugated antibodies and ECL SuperSignal detection kit were
from Pierce (Rockford, IL, USA). Anti-Actin and anti P-TauT231
antibodies were from Sigma Chemical Co (Milano, Italy).
CELL CULTURE
Hippocampal neurons cultures were prepared from E18-E19
rat hippocampi as previously described, with minor modifica-
tions (Brewer et al., 1993; Bulbarelli et al., 2009). Neurons were
plated on polylysine coated dishes (60 mm diameter, 5 × 105
cells/dish). The medium for cell culture was NBM containing 2%
B27 supplement and 12.5 nM glutamate. After 72 h in culture,
half of the cell medium was replaced with NBM w/o glutamate
and supplemented with 1-β-D arabinofuranosylcytosine (Ara-C)
(5 µM final concentration) to prevent glial proliferation. Cells
were maintained at 37◦C, 5% CO2 for 8 days before treat-
ment. All experiments were carried out in accordance with the
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guidelines established by the European Community Council and
were approved by the Italian Ministry of Health (DL 116/92).
Adequate measures were always taken to minimize animal pain
or discomfort.
OXYGEN AND GLUCOSE DEPRIVATION TREATMENT
Primary hippocampal neurons were subjected to OGD as previ-
ously described (Bulbarelli et al., 2012). Briefly, culture medium
was replaced by through exchange with a glucose-free balanced
salt solution (BSS; NaCl 130 mM, KCl 5.5 mM, CaCl2 1.8 mM,
MgCl2 1 mM, HEPES 20 mM). Then cells incubated in a hypoxia
chamber (Billups–Rothenberg, Del Mar, CA) saturated for 10 min
with 5% CO2: 95% N2 were sealed at 37◦C for 3 h. After OGD,
cells were supplemented with the restoration solution: glucose
(final concentration 5 mM) and B27 (final concentration 2%)
in NBM.
Cells were maintained in normal culture conditions (37◦C in
a 5% CO2 atmosphere) for different times of restoration: one
hour (R 1 h) and overnight (R o/n) after the reestablishment of
normoxia. Untreated hippocampal cells were incubated in NBM
supplemented with 2% B27 in a 5% CO2 atmosphere.
TREATMENTS WITH INHIBITORS
5-Hydroxy-1,4-naphtoquinone (juglone) was dissolved in
dimethyl sulfoxide (DMSO) to obtain a 10 mM stock solution and
used as Pin1 catalytic activity inhibitor, accordingly to previous
studies (Chao et al., 2001; Galas et al., 2006). Hippocampal cells
were incubated with a 10 µM juglone final concentration for
8 h as already described (Bulbarelli et al., 2009), or with 1 µM
lactacystin, an inhibitor of ubiquitin-proteasome degradation
system, for 16 h (Cazzaniga et al., 2007). According to literature
Gsk-3 kinase activity was inhibited by means of lithium chloride
administrated to hippocampal cells at 10 mM final concentration
for 1 h (Stambolic et al., 1996) or SB-216763 administrated at
10 µM (Facci et al., 2003) for 3 h accordingly to experimental
indications obtained in our cellular model.
IMMUNOPRECIPITATION
Cells subjected or not to OGD or to inhibitor treatments for
different times, were rinsed twice with phosphate-buffered saline
(PBS) and harvested by scraping with a rubber policeman after
lysis with non denaturising buffer (1% Nonidet P-40, 50 mM
Tris-HCl, pH 7.4, 150 mM NaCl) in presence of complete pro-
tease inhibitor cocktail and phosphatase inhibitors (2 mM Na
orthovanadate, 1 mM Na fluoride, 1 mM Na pyrophosphate).
Then, immunoprecipitation of the endogenous HIF-1α, Pin1
or P-Ser/Thr-Pro (MPM2) proteins was performed from 1 mg
of total proteins using anti-HIF-1α (1:100), anti-Pin1 (1:100),
anti-MPM2 (1:100) and Dynabeads protein G according to the
manufacturer’s instruction. Immunoprecipitated proteins were
eluted in lauryl-dodecyl sulphate (LDS) lysis buffer with reducing
agent (Life Technologies) and boiled for 10 min at 70◦C before
analysis on NuPAGE Bis-Tris 4–12% polyacrylamide gels.
SDS-PAGE ELECTROPHORESIS AND IMMUNOBLOTTING
Samples were obtained after lysis with denaturising buffer (2%
SDS lysis, 50 mM Tris-HCl, pH 6.8 plus protease inhibitor
cocktail and phosphatase inhibitors). The total protein amount
was evaluated by means of Bicinchoninic acid assay and 25 µg
of each sample were subjected to on SDS-polyacrylamide gel
electrophoresis (PAGE) on 12.5% polyacrylamide gels. For
immunoprecipitation, samples obtained were loaded on NuPAGE
Bis-Tris 4–12% gels. After SDS-PAGE electrophoresis samples
were transferred to a nitrocellulose membrane (Amersham, GE
Healthcare Europe GmbH, Milano, Italy) and proteins revealed
by Ponceau staining (Sigma Chemical Co., Milano, Italy). Mem-
branes were blocked in TBS-Tween 0.1% buffer containing 5%
non-fat milk or TBS-Tween 0.2% buffer containing 3% bovine
serum albumin, and probed with specific antibodies in TBS-T
buffer containing 5% non-fat milk or 5–3% bovine serum
albumin according to manufacturer’s instructions. Immunoblot-
ting was performed using anti-Pin1 (1:1000), anti-P-Pin1S16
(1:1000), anti-HIF-1α (1:1000), anti-ubiquitin (PD41) (1:1000),
anti LDH (1:2000), anti-BACE1 (1:1000), anti-P-Ser/Thr-Pro
(MPM2) (1:1000), anti-P-TauT231 (1:5000), anti-Tau (1:1000) and
anti-β-actin (1:1500). Immunoreactive proteins were revealed
by enhanced chemiluminescence (ECL) and semi-quantitatively
estimated by a KODAK image station 2000R. Normalization was
carried out with respect to the amount β-actin in the same
sample.
PPIase ASSAY
Pin1 activity was measured according to the methods of Janowski
et al. (1997) and Hennig et al. (1998) with slight modifications
as follows (Janowski et al., 1997; Hennig et al., 1998). Stock
solutions for the protease-free assay was prepared as described:
the phosphorylated substrate Ac-AA(pS)PR-pNA was dissolved in
0.47 M LiCl/trifluoroethanol (anhydrous) at 30 mg/ml concentra-
tion; trypsin protease was dissolved in 35 mM HEPES, pH 7.8 at
50 mg/ml concentration.
For a typical measurement, to determine the PPIase activity
originating from Pin1, the sample buffer (35 mM HEPES, pH 7.5)
was incubated in a temperature-controlled cuvette holder at 4◦C.
Then Ac-AA(pS)PR-pNA (0.02 mg/ml) was added and the reac-
tion was started by the injection of trypsin (0.1 mg/ml). After the
initial burst phase where all trans peptides were cleaved, protein
samples obtained after lysis, as described for immunoprecipi-
tation, was added to the reaction. The absorption at 390 nM,
which detects the formation of free p-nitroanilide (pNA), was
monitored using a Beckman Coulter DU 800 spectrophotometer.
The enzymatic activity of Pin1 in the sample (unit/mL) was
calculated as follows: absorbance (OD) ∗ total volume/9620 M−1
cm−1 (extinction coefficient ) ∗ volume of sample in mL ∗ 1 cm
(d). Normalization was carried out with respect to total protein in
the same sample.
Unit/mL =(
(1Abs/min) ∗ (V tot in mL))/(ε ∗ (V of sample in mL) ∗ d)
The measured activity was normalized to the total protein
content of the lysate.
STATISTICAL ANALYSIS
All data are expressed as mean ± SEM of three separate experi-
ments performed in triplicate. The differences were calculated by
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means of Student’s t-test. A p value <0.05 was considered to be
statistically significant.
RESULTS
EFFECTS OF THE OXYGEN AND GLUCOSE DEPRIVATION ON HIF-1α
PROTEIN EXPRESSION, Pin1 PHOSPHORYLATION AND ACTIVITY IN
HIPPOCAMPAL NEURONS CULTURES
Hippocampal cells were subjected to OGD for 3 h. Following
the treatment, we investigated the HIF-1α protein levels after
1 hour (R 1 h) and overnight (R o/n) of normal oxygen and
glucidic conditions restore. As already demonstrated by our group
(Bulbarelli et al., 2012), hippocampal neuron viability is not
affected by the OGD treatment.
As shown in Figure 1A, HIF-1α protein level increased at
R 1 h (60%) remaining significantly higher than control up to
R o/n. Concomitantly, we detected that HIF-1α ubiquitination
state was decreased about 40% at R 1 h almost unvarying at R o/n
(Figure 1B).
Relatively to HIF-1α expression increase after normal con-
dition restoration (post-OGD) we examined lactate dehydroge-
nase (LDH) and BACE1 protein expression, two proteins whose
genes are under HIF-1α transcriptional regulation. We observed
that LDH expression increased about 70% already at R 1 h,
slightly decreasing during overnight, while BACE1 protein level
significantly increased during o/n, reaching 150% of increment
(Figure 1A).
Contemporary we observed that Pin1 activity was reduced in a
time dependent manner of about 40% at R 1 h, decreasing till 60%
during overnight (Figure 2A). In addition, in the same conditions
we assessed Pin1S16 phosphorylation (a state that inhibits Pin1
binding to its substrate): the isomerase was significantly phos-
phorylated at R 1 h (150%) slightly decreasing at R o/n (110%;
Figure 2B).
PHOSPHORYLATION OF HIF-1α Ser/Thr-Pro MOTIFS FOR SPECIFIC Pin1
RECOGNITION AND INTERACTION
We examined the amino acid HIF-1α protein sequence to evaluate
the presence of conserved Ser/Thr-Pro motifs potentially recog-
nizable by Pin1 when phosphorylated (Flügel et al., 2007), by
means of the alignment of human (Q16665) (Iyer et al., 1998) and
rat (O35800) HIF-1α protein sequence (Kietzmann et al., 2001;
Align tool EXPASY). As shown the analyses revealed a number of
these motifs in HIF-1α sequence. In particular, the Gsk-3β target
residue Ser589 precedes a proline in one of the above mentioned
Ser/Thr-Pro motifs (Figure 3A).
Therefore in order to find one or more HIF-1α phospho-
rylated Ser/Thr-Pro motifs (PSer/Thr-Pro), we employed the
monoclonal antibody MPM2, which specifically recognizes the
PSer/Thr-Pro motifs. Immunoprecipitated HIF-1α protein was
identified by MPM2 antibody, confirming that HIF-1α protein
contains PSer/Thr-Pro motifs under normal culture condi-
tions. On the other hand, among proteins immunoprecipitated
with MPM2, HIF-1α was identified by a specific antibody
(Figure 3B).
Given that this phosphorylation might allow Pin1 inter-
action with its hypothetic substrate, we therefore tested in
our neuronal model whether HIF-1α associates with Pin1 by
FIGURE 1 | In post-OGD conditions HIF-1α protein levels increases
while its ubiquitination state decreases. Cells were subjected to OGD
treatment and restoration of normoxic and glucidic conditions for different
times (R 1 h, R o/n). (A) Cells were collected and lysed with 2% SDS lysis
buffer. Equal amounts of samples (as protein content) were subjected to
SDS-PAGE and western blot analysis. HIF-1α, LDH, BACE1 levels were
detected by specific antibodies, revealed by enhanced chemiluminescence
(ECL) and semi-quantitatively determined by a KODAK image station
2000R. Anti-β-actin antibody was employed to confirm equal protein loading
in the different lanes. Results obtained are shown on the bar-graphs.
Normalization was carried out with respect to the β-actin amount in the
same sample. (B) HIF-1α ubiquitination state was evaluated after
immunoprecipitation using western blot analysis. Cells were collected and
lysed in non denaturising NP40 buffer. Western blot analysis performed on
immunoprecipitated proteins showed bands corresponding to ubiquitinated
HIF-1α protein (140 kDa), HIF-1α protein (110 kDa). Proteins were detected
by specific antibodies (anti-HIF-1α; anti-ubiquitin), revealed by ECL and
semi-quantitatively determined by a KODAK image station 2000R and the
results obtained are shown on the bar-graphs. IP, immunoprecipitation; WB,
western blot. Data represent the mean ± SEM of three separate
experiments performed in triplicate. Statistical significance is obtained with
Student’s t-test in comparison with controls. ∗ p < 0.05, ∗∗ p < 0.01.
co-immunoprecipitation of endogenous HIF-1α or Pin1. As
shown in Figure 3C, HIF-1α was detected among proteins
immunoprecipitated by the anti-Pin1 antibody as well Pin1 was
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FIGURE 2 | Pin1 inhibition in post-OGD conditions. (A) PPIase activity
decreases during restoration of normal cultures conditions following OGD.
Cells were lysed and collected in non denaturising NP40 buffer at R 1 h and
R o/n. Pin1 isomerase activity against Ac-AA(pS)PR-pNA substrate were
measured as described in materials and methods. The measured activity
was normalized to the total protein concentration of the lysate. (B) Pin1S16
phosphorylation increases in response to OGD treatment. Cells were lysed
in the presence of 2% SDS lysis buffer after OGD treatment and restoration
of normoxic and glucidic conditions for different times (R 1 h, R o/n). Total
protein content were subjected to SDS-PAGE and Western blot analysis.
P-Pin1S16 and total Pin1 were detected by specific antibodies and revealed
by ECL, and semi-quantitatively determined by a KODAK image station
2000R. Anti-β-actin antibody was employed to confirm equal protein loading
in the different lanes. Results obtained are shown on the bar-graphs. The
amount of P-Pin1S16 correspond to phospho-protein level on Pin1 total
protein. Normalization was carried out with respect to the β-actin amount in
the same sample. Data represent the mean ± SEM of three separate
experiments performed in triplicate. Statistical significance is obtained with
Student’s t-test in comparison with controls. * p < 0.05, ** p < 0.01.
detected in the protein complex immunoprecipitated by the anti
HIF-1α antibody suggesting that HIF-1α and Pin1 might interact
each other. Immunoprecipitation with LDH antibody was per-
formed as negative control.
Pin1 INHIBITION AFFECTS HIF-1α DEGRADATION PATHWAY
In order to understand whether Pin1 plays a role in HIF-1α
ubiquitination and the following degradation, hippocampal cells
were treated for 8 h with 10 µM juglone, an irreversible inhibitor
of Pin1 catalytic activity. As expected, juglone treatment trig-
gered a strong inhibition of Pin1 isomerase activity (almost 75%;
Figure 4A).
The effect of Pin1 inhibition was firstly studied in the whole
lysate. As shown in Figure 4B, HIF-1α protein level increased of
about 70% with respect to control level. Since it is known that
Pin1 promotes Tau dephosphorylation (Bulbarelli et al., 2009),
a more convincing evidence of the Pin1 inhibition was obtained
evaluating Tau phosphorylation on residue Thr231. As expected
we observed an increase in Tau phosphorylation.
In parallel, to evaluate the proteasomal degradation of HIF-1α
in our cellular model, cells were incubated for 16 h with 1 µM
lactacystin an irreversible proteasome inhibitor, revealing HIF-1α
protein increment of about 80%. Data obtained are comparable to
ones detected after juglone, suggesting that Pin1 might be engaged
in the HIF-1α degradation. Contemporary, immunoprecipitated
HIF-1α resulted about 35% less ubiquitinated than in untreated
cells (Figure 4C).
Gsk-3β INHIBITION INFLUENCES Pin1/HIF-1α ASSOCIATION
To assess the involvement of Gsk-3β activity in phosphorylation
of Ser/Thr-Pro motifs, hippocampal neurons were incubated in
presence of 10 mM LiCl for 1 h, or in presence of 10 µM SB-
216763 for 3 h. Then we performed HIF-1α protein immunopre-
cipitation to analyse phosphorylation state in Ser/Thr-Pro motifs
and the amount of Pin1 co-immunoprecipitated.
As shown in Figure 5A, phosphorylation of Ser/Thr-Pro
motifs was greatly reduced in cells treated with the inhibitors,
concomitantly to a considerable decrease in the amount of co-
immunoprecipitated Pin1, although total Pin1 amount resulted
almost unchanged (Figure 5B). In addition, we observed the HIF-
1α ubiquitination decrease and a slight enhance of protein level
both in the immunoprecipitated fractions (Figure 5A) and in the
total lysates (Figure 5B), indicating a possible reduction in the
HIF-1α protein degradation.
In order to confirm the Gsk-3β inhibition, Figure 5B shows
the increase of Gsk-3β inhibitory phosphorylation on Ser9 after
LiCl treatment, accordingly to Martin et al. (2009). Moreover,
inhibitory effect on Gsk-3β activity was assessed evaluating
Tau phosphorylation on Thr231 residue, a well known target
of kinase activity (Figure 5B; Lin et al., 2007). As expected,
after treatment with both the inhibitors, Tau phosphorylation
decreased.
EFFECTS OF THE OXYGEN AND GLUCOSE DEPRIVATION ON Gsk-3β
PHOSPHORYLATION AND HIF-1α/Pin1 ASSOCIATION
Considering results above, to investigate whether HIF-1α ubiq-
uitination decrease in post-OGD conditions might correlate to
Gsk-3β inhibition, the P-Gsk-3βS9 levels were evaluated. As shown
in Figure 6A, Gsk-3βS9 inhibitory phosphorylation increased
about 40% at R 1 h and duplicated at R o/n, while total Gsk-
3β protein resulted unchanged during the treatment. Concomi-
tantly we detected a significant decrease in Ser/Thr-Pro motifs
phosphorylation, revealed by anti-MPM2, on the immunoprecip-
itated HIF-1α protein at R 1 h (Figure 6B). At R o/n we observed
a slightly increase of P-Ser/Thr-Pro motifs that however did not
reach control levels (Figure 6B). Moreover, we also evaluated the
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FIGURE 3 | HIF-1α phosphorylation on PSer/Thr-Pro motifs and
interaction with Pin1. (A) Alignment of amino acid sequences of the
HIF-1α oxygen degradation domain (ODD) (aa 402-604) from HIF-1α
human and rat homologues. PSer/Thr-Pro motifs are highlighted in dark
gray. (B) Cells were collected and lysed in non denaturising NP40 buffer.
Immunoprecipitated HIF-1α is recognized by MPM2 antibody, vice versa
among immunoprecipitated MPM2 epitopes, HIF-1α antibody detects
the corresponding protein. (C) Co-immunoprecipitation of endogenous
HIF-1α and Pin1 proteins in primary rat hippocampal cells lysed in non
denaturising NP40 buffer. Immunoprecipitation with LDH antibody was
performed as negative control. Western blotting analysis performed on
immunoprecipitated proteins showed a 110 kDa and a 18 kDa band
corresponding to HIF-1α and Pin1 respectively. Proteins detected by
specific antibodies, were revealed by ECL. IP, immunoprecipitation; WB,
western blot; MPM2, antibody against phosphorylated Ser/Thr-Pro
motifs.
co-immunoprecipitated Pin1 amount: a considerable decrease in
HIF-1α/Pin1 association was revealed at R 1 h, while the Pin1
amount at R o/n was quite equivalent to the control (Figure 6B).
DISCUSSION
Coexistence of ischemic and neurodegenerative pathology seems
to have a deep impact on the expression of the dementia,
suggesting common mechanisms interactions. Cerebrovascular
diseases such as ischemia leading to cerebral blood flows reduc-
tion (hypoperfusion) might indeed initiate and/or accelerate the
neurodegeneration cascade via amyloid deposition and synaptic
neuronal dysfunction (Iadecola, 2010; Kalaria and Ihara, 2012).
Depletion of oxygen and glucose sources typical of brain ischemia
(Brouns and De Deyn, 2009), results in the activation of highly
heterogeneous phenomena in which one of the key component
is the transcription factor HIF-1. Therefore protein levels of its
hypoxia responsive α subunit (HIF-1α) are finely regulated by
degradation through ubiquitin-proteasome system that may be
induced by hydroxylation (VHL-mediated) and as recently sug-
gested by phosphorylation (Gsk-3β-mediated; Flügel et al., 2007,
2012). Here we propose that, in hippocampal cellular model,
the Pin1 plays an important role in Gsk-3β-mediated HIF-1α
ubiquitination/degradation pathway.
In cortical neurons, as already demonstrated, HIF-1α pro-
tein levels are maintained higher for long time after reperfu-
sion following OGD by PI3K/Akt signaling (Zhang et al., 2009).
Since the PI3K/Akt pathway is known to inhibit Gsk-3β and to
regulate HIF-1α in a cell type specific manner (Mottet et al.,
2003), we speculate that in neuronal cells HIF-1α degrada-
tion might be also regulated by the Gsk-3β pathway working
in parallel or in alternative to the well known VHL-mediated
mechanism.
Gsk-3β regulates the ubiquitination state of several targets in
cooperation with Pin1 (Liou et al., 2011), that mediating prolyl
cis/trans isomerization can influence the stability of its substrates
via phosphorylation-dependent ubiquitin-mediated proteolysis
both under physiological and pathological conditions; accord-
ingly, Pin1 might interact and catalyze the isomerization of HIF-
1α phosphorylated by the kinase under physiological conditions.
Interestingly, here we show, for the first time in neurons, that
OGD treatment results in a Pin1 activity reduction, an event that
in turn leads to HIF-1α protein levels increase. Indeed, although
the transcription factor should be immediately degraded in nor-
moxic conditions by VHL-mediated pathway restoring control
levels (Semenza, 2010), in hippocampal cells high levels of HIF-
1α protein are detectable at R 1 h and maintained for long time
(even up to overnight) after normal oxygen and glucidic condi-
tions restore following OGD. Moreover, HIF-1α high levels are
accompanied by a significant decrease of protein ubiquitination
state, indicating an impairment in degradation pathway.
Concerning to Pin1, OGD triggers a partial inhibition
of its enzymatic activity and also increases Ser16 residue
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FIGURE 4 | HIF-1α protein levels increases in parallel to a decrease of
its ubiquitination state after juglone (jug) treatment. Cells were
treated or not with juglone 10 µM for 8 h. (A) PPIase activity
decreases in cells subjected to juglone treatment. Cells were lysed and
collected in non denaturising NP40 buffer and Pin1 isomerase activity
against Ac-AA(pS)PR-pNA substrate were measured as described in
Section materials and methods. The measured activity was normalized
to the total protein concentration of the lysate. (B) Neurons were
treated or not with juglone or lactacystin (lac) 1 µM for 16 h. Equal
amounts of total cell lysates (in the presence of 2% SDS) were
subjected to SDS-PAGE and western blot analysis. HIF-1a, Tau, P-TauT231
levels were detected by specific antibodies, revealed by ECL and
semi-quantitatively determined by a KODAK image station 2000R. HIF-1α
results obtained are shown on the bar-graphs. Anti-β-actin antibody was
employed to confirm equal protein loading in the different lanes,
normalization was carried out with respect to the β-actin amount in the
same sample. (C) HIF-1α ubiquitination state decreases after juglone
treatment. Western blot analysis showed a 110 kDa and 140 kDa bands
corresponding to HIF-1α and to ubiquitinated HIF-1α protein respectively.
Proteins were detected by specific antibodies (anti-HIF-1α; anti-ubiquitin),
revealed by ECL and semi-quantitatively determined by a KODAK image
station 2000R. Results obtained are shown on the bar-graphs. IP,
immunoprecipitation; WB, western blot. Data represent the mean ±
SEM of 3 separate experiments performed in triplicate. Statistical
significance is obtained with Student’s t-test in comparison with
controls. * p < 0.05, ** p < 0.01.
phosphorylation in the binding domain. Therefore, on one
side Ser16 phosphorylation may inhibit Pin1 function in
recognizing and binding its substrates, on the other side
Pin1 isomerization activity might be diminished by oxida-
tive modification occurring in the catalytic domain (Lu et al.,
2002; Lonati et al., 2011). Indeed, as already known oxida-
tive stress might reduce Pin1 function (Butterfield et al.,
2006a,b).
Considering data above, we suppose that Pin1 partial inhibi-
tion may directly affect the HIF-1α degradation pathway, thus we
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FIGURE 5 | Lithium Chloride (LiCl) or SB-216763 treatment inhibits
Gsk-3β leading to a decrease in HIF-1α phosphorylation on
PSer/Thr-Pro motifs and in HIF-1α/Pin1 interaction. Cells were treated
or not with LiCl 10 mM for 1 h or SB-216763 10 µM for 3 h. (A) Western
blot analysis performed on HIF-1α immunoprecipitated protein revealed a
decrease of the ubiquitination state (anti-ubiquitin), of Ser/Thr-Pro motifs
phosphorylation (anti-MPM2) and of Pin1 co-immunoprecipitation
(anti-Pin1). (B) Equal amounts of total cell lysates (in the presence of 2%
SDS) were subjected to SDS-PAGE and Western blot analysis. HIF-1α, Tau,
P-TauT231, Gsk-3β and P-Gsk-3βS9 and Pin1 levels were detected by specific
antibodies and revealed by ECL. TauT231 phosphoryalation as well known
Gsk-3β target was assessed to evaluate the kinase inhibition. Anti-β-actin
antibody was employed to confirm equal protein loading in the different
lanes. IP, immunoprecipitation; WB, western blot; MPM2, antibody against
phosphorylated Ser/Thr-Pro motifs.
evaluated if Pin1/HIF-1α interaction might be required for HIF-
1α ubiquitination.
Firstly, after exploring in HIF-1α amino acid sequence the
presence of motifs constituted by serine/threonine residues
preceding a proline (Ser/Thr-Pro) that, when phosphorylated,
allows Pin1 to specifically recognise its substrates, we found
these phosphorylated motifs in HIF-1α protein, employing the
anti-MPM2 antibody (which specifically recognizes the PSer/Thr-
Pro motifs). Given that this evidence pinpoints the transcription
factor as an hypothetic target for Pin1 binding, we provided the
evidence of HIF-1α/Pin1 association by co-immunoprecipitation,
indicating that the transcription factor and the isomerase may
interact each other.
Afterwards, we evaluated the HIF-1α level expression, inhibit-
ing Pin1 catalytic activity by means of juglone treatment. Since
FIGURE 6 | In post-OGD conditions P-Gsk-3βS9 levels increases. Cells
were subjected to OGD treatment and restoration of normoxic and glucidic
conditions for different times (R 1 h, R o/n). (A) Cells were collected and
lysed with 2% SDS lysis buffer. Equal amounts of samples (as protein
content) were subjected to SDS-PAGE and western blot analysis. Gsk-3β
and P-Gsk-3βS9 levels were detected by specific antibodies, revealed by
ECL and semi-quantitatively determined by a KODAK image station 2000R.
Anti-β-actin antibody was employed to confirm equal protein loading in the
different lanes. Results obtained are shown on the bar-graphs. The amount
of P-Gsk-3βS9 correspond to phospho-protein level on Gsk-3β total protein.
Normalization was carried out with respect to the β-actin amount in the
same sample. (B) HIF-1α phosphorylation on Ser/Thr-Pro motifs and
HIF-1α/Pin1 interaction was evaluated after HIF-1α immunoprecipitation
using western blot analysis. Cells were collected and lysed in non
denaturising NP40 buffer. Western blot analysis performed on
immunoprecipitated proteins showed bands corresponding to Pin1 protein
(18 kDa), HIF-1α protein and HIF-1α phosphorylated on Ser/Thr-Pro motifs
(110 kDa). Proteins were detected by specific antibodies (anti-HIF-1α;
anti-MPM2; anti-Pin1), revealed by ECL and semi-quantitatively determined
by a KODAK image station 2000R and the results obtained are shown on
the bar-graphs. IP, immunoprecipitation; WB, western blot. Data represent
the mean ± SEM of three separate experiments performed in triplicate.
Statistical significance is obtained with Student’s t-test in comparison with
controls. * p < 0.05, ** p < 0.01.
we had already established that juglone-mediated Pin1 inhibition
leads to TauT231 phosphorylation increase (Bulbarelli et al., 2009),
here we show Tau phosphorylation augment after juglone as
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positive control of the treatment. Under conditions in which Pin1
enzymatic activity is highly repressed, data obtained showed that
HIF-1α levels strongly increase in parallel with a mild decrease
of its ubiquitination state, demonstrating that Pin1 affects pro-
tein ubiquitination and degradation. Interestingly the HIF-1α
levels observed after juglone treatment were comparable to that
observed in proteasome inhibited cells suggesting that in our
cellular model, Pin1 might play a main role in the fate of the
transcription factor. Taking into account that HIF-1α and Pin1
co-immunoprecipitate, it is plausible that the enzyme catalyzes
HIF-1α peptydil-prolyl conformational isomerization.
As Liou and colleagues reported (Liou et al., 2011), Pin1 can
cooperate synergistically with Gsk-3β in ubiquitination of a wide
range of proteins, therefore the role of this kinase in Ser-Thr/Pro
phosphorylation and the consequent interaction between Pin1
and HIF-1α have been investigated.
Among the several Gsk-3β phosphorylation consensus motifs
in HIF-1α amino acid sequence individuated by Flügel et al.
(2007), we observed that the Ser589 is neighboring to a proline
constituting a Ser-Thr/Pro motif, which phosphorylated might be
the consensus for Pin1 recognition. Therefore we speculate that
this sequence could be significant in the HIF-1α stability.
To understand whether decreasing HIF-1α phosphorylation
levels might affect Pin1/HIF-1α interaction, we employed two
different Gsk-3β activity inhibitors: the well known LiCl and
the more specific SB-216763. Since LiCl treatment induces Gsk-
3β inhibitory phosphorylation on Ser9 (Martin et al., 2009),
here we confirme the kinase inhibition showing an increase in
Ser9 phosphorylation. On the contrary, SB-216763 induces the
dephosphorylation of Gsk-3β at Ser9 (Jaeger et al., 2013), nev-
ertheless inhibits Gsk-3β activity in an ATP competitive manner
(Cross et al., 2001).
Interestingly, data obtained after the treatment with Gsk-
3β activity inhibitors showed: (i) a strong reduction of
phosphorylated Ser/Thr-Pro motifs of HIF-1α protein; (ii) a
considerable decrease of co-immunoprecipitated Pin1 amount;
(iii) an higher HIF-1α protein level with respect to control.
The reduction of HIF-1α phosphorylated motifs accompanied
by protein levels increase, give reason for Pin1 binding decrease,
suggesting that Pin1 might be involved in the Gsk-3β/HIF-1α
stability regulation independent from the VHL pathway (Flügel
et al., 2007). Indeed, Flügel et al. (2007) suggest that the reg-
ulation of HIF-1α degradation is not limited by the presence
of oxygen, resulting therefore independent of HIF-1α hydroxy-
lation and VHL-E3 ligase complex. Moreover, the F-box protein
Fbw7, an E3 ubiquitin ligase, has been recently identified as
novel critical component in HIF-1α degradation that is recruited
to HIF-1α after its phosphorylation by Gsk-3β (Flügel et al.,
2012): in a wider framework we can speculate that Pin1 might
be involved in the Gsk-3β/Fbw7 HIF-1α degradation system.
Taken together our experiments indicate for the first time that
Pin1 interacts with HIF-1α in order to regulate the transcription
factor protein levels. Therefore the decrease of Pin1 ability to
bind and isomerize PSer/Thr-Pro motif might correlate with
high levels of HIF-1α observed in post-OGD conditions (see a
schematic representation in Figure 7). To deepen the OGD effect
on HIF-1α and Pin1 interaction we analyzed Gsk-3βS9, HIF-1α
Ser/Thr-Pro motif phosphorylation and HIF-1α/Pin1 association.
Interestingly, here we show that, Gsk-3βS9 inhibitory phospho-
rylation increased at R 1 h, correlating both to the Ser/Thr-Pro
motifs phosphorylation decrease and HIF-1α/Pin1 association
reduction. Vice versa at R o/n we observed a slightly increase
of P-Ser/Thr-Pro motifs that however did not reach control
levels and the co-immunoprecipitated Pin1 amount was quite
equivalent to the control. This observation apparently in contrast
with the HIF-1α increase might be explained by the fact that
although Pin1 might be able to bind the transcription factor,
since Pin1S16 phosphorylation decreased, the isomerase resulted
enzymatically inhibited (see the PPIase assay in Figure 2). Hence,
we hypothesize that in post-OGD hippocampal neurons, Gsk-3β
and Pin1 inhibition lead to a decrease of HIF-1α ubiquitination
affecting the consequent degradation of the transcription factor.
Since, unconventional VHL-independent HIF-1α degradation
pathway involving RACK1 has been already described (Isaacs
et al., 2002; Semenza, 2010), here we propose that Pin1/Gsk-3β-
mediated HIF-1α degradation may be a functionally predominant
pathway in our cellular model, that instead of VHL requires the
involvement of the E3 ubiquitin ligase Fbw7.
Furthermore, it has been recently proposed that Pin1 inhibits
Gsk-3β activity (Ma et al., 2012) promoting Ser9 phosphoryla-
tion, however in our cellular model subjected to OGD this event
FIGURE 7 | Model showing HIF-1α degradation pathway mediated by
Pin1/Gsk-3β. In healthy hippocampal neurons Gsk-3β phosphorylates the
HIF-1α transcription factor on Ser/Thr-Pro motif potentially recognizible by
Pin1. After phosphorylation Pin1 is able to recognize and bind the cis form
of HIF-1α (circle form), and catalyzes its isomerization to trans conformation
(square). The E3 ligase complex having a structural preference for
phosphorylated substrates in trans conformation to favors ubiquitination
and the consequent degradation of the transcription factor via proteasome.
In post-OGD neurons, instead, Gsk-3β is inhibited by phosphorylation on
Ser9, therefore HIF-1α is not phosphorylated on Ser/Thr-Pro motif resulting
unrecognizable by Pin1. Moreover Pin1 itself is inhibited by phosphorylation
on Ser16, and its enzymatic activity is blocked leading to loss of HIF-1α
cis/trans isomerization. HIF-1α is not more ubiquitinated and degradated via
proteasome, accumulating in its cis conformation.
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seems to be independent from Pin1, deserving future experiments
to deeply investigate.
For all above mentioned, under condition mimicking an
ischemic event influencing Pin1 activity might be extremely detri-
mental causing intracellular molecular mechanisms deregulation,
eventually leading to pathophysiological conditions such as in
AD. In fact Pin1 has been identified as a common regulator of
both Tau and APP pathologies (Lu and Zhou, 2007), regulating
Tau phosphorylation levels and the NFTs formation as well as
levels of Aβ peptide production (Liou et al., 2003; Pastorino et al.,
2006).
Our group has recently demonstrated that after OGD the
amount of peptide Aβ42 increases both in neurons and in cere-
brovascular endothelial cells (Bulbarelli et al., 2012), probably
related to the increase of HIF-1α transcriptional activity (Zhang
et al., 2007).
Notably, in parallel to HIF-1α high levels we observed the
increase of BACE1 protein under our experimental conditions.
Hence, in our hypothesis, the alteration in Pin1-mediated HIF-
1α degradation resulting from an ischemic event, might accelerate
APP amyloidogenic metabolism/Aβ42 production in neurons,
supporting the theory that cerebral hypoperfusion induces Aβ
deposition. As well in AD the Pin1 deregulation might lead to a
more rapid HIF-1α stability/activation inducing the expression
of genes implicated in pathological intracellular mechanisms
involved in vascular diseases and neurodegeneration.
In view of that there could be a pathogenic synergy between
the two disease processes, stroke and AD might effectively share
common risk factors (Iadecola, 2010): in this scenery the role of
Pin1 in HIF-1α isomerization and degradation may outcome as
central mechanism in vascular damages vs. AD and vice versa.
Furthermore, considering that it has been recently demonstrated
the correlation between Pin1 activity reduction and the essential
hypertension (Wang et al., 2013a,b), the isomerase partial loss of
function might be detrimental in multiple interrelated disease;
hence the role of Pin1 in HIF-1α regulation might contribute to
the morbidity of hypertension, becoming in turn a risk factor for
stroke and AD.
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